Fig. 7
From: Signaling pathways in obesity: mechanisms and therapeutic interventions
Timeline of anti-obesity medications approved by the FDA or EMA from the late nineteenth century until today (the red dashed line indicates long-term use while the blue dashed line indicates short-term use)
